What is American Shared Hospital Services's earnings per share (EPS)?

American Shared Hospital Services (AMS) reported diluted earnings per share of -$0.23 for fiscal year 2025. This represents a -169.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

American Shared Hospital Services (AMS) Financials

AMS

Trailing 12 months to June 30, 2026

Revenue $30.4M +4.0% YoY

Net Income -$1.8M +27.3% YoY

EPS (Diluted) -$0.25 +34.2% YoY

Free Cash Flow -$433K +95.0% YoY

Market Cap $8.8M as of Oct 9, 2026

Price / Sales 0.3x on $30.4M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.4x on $23.1M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMS SEC filings page.

American Shared Hospital Services (AMS) reported $30.4M in revenue over the twelve months to Jun 30, 2026, up 4.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMS FY2025 2026-10-03

Revenue held near $28M, but margin compression and heavy reinvestment turned a formerly cash-generative model into short-term balance-sheet pressure.

The key break is not sales: revenue was nearly unchanged from FY2024 to FY2025, while gross margin fell from 32.4% to 18.0%, pushing operating losses deeper. Yet operating cash flow recovered to $3.1M from $0.2M even as free cash flow remained -$4.5M, showing that non-cash expenses and operating movements supported cash generation while capital spending still consumed it.

Debt removal did not eliminate near-term obligations: reported long-term debt fell to $0, but current liabilities rose to $23.4M and the current ratio fell to 0.8x. Most reported liabilities therefore sit in the current portion of the balance sheet, leaving less short-term coverage than in FY2024.

Capital intensity has become central to the model. Capital spending exceeded operating cash flow in each of FY2023 through FY2025, producing negative free cash flow even when operations themselves generated cash; in FY2025, spending was $7.6M against operating cash flow of $3.1M.

Financial Health Signals

Financial Health Score 37/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of American Shared Hospital Services's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

American Shared Hospital Services has an operating margin of -12.8%, meaning the company loses $13 on every $100 of revenue. This results in a profitability score of 15/100. This is down from -9.9% the prior year.

Growth

American Shared Hospital Services's revenue declined 0.9% year-over-year, from $28.3M to $28.1M. This contraction results in a growth score of 75/100.

Leverage

American Shared Hospital Services carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

American Shared Hospital Services's current ratio of 0.76 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While American Shared Hospital Services generated $3.1M in operating cash flow, capex of $7.6M consumed most of it, leaving -$4.5M in free cash flow. This results in a low score of 9/100, reflecting heavy capital investment rather than weak cash generation.

Returns

American Shared Hospital Services posts a -6.5% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 16/100. This is down from 8.7% the prior year.

Altman Z-Score Distress

0.47

American Shared Hospital Services scores 0.47, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

American Shared Hospital Services passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

American Shared Hospital Services reported a net loss of $1.6M while generating $3.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

American Shared Hospital Services reported an operating loss of $3.6M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$8.4M

YoY+19.2%

QoQ+19.0%

5Y CAGR+13.5%

10Y CAGR+6.4%

American Shared Hospital Services generated $8.4M in revenue in Q2 2026. This represents an increase of 19.2% from the same quarter a year earlier. Against the prior quarter it is up 19.0%.

EBITDA

$436K

YoY-54.8%

QoQ+17.8%

American Shared Hospital Services's EBITDA was $436K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 54.8% from the same quarter a year earlier. Against the prior quarter it is up 17.8%.

Net Income

-$514K

YoY-83.6%

QoQ+16.0%

American Shared Hospital Services reported -$514K in net income in Q2 2026. This represents a decrease of 83.6% from the same quarter a year earlier. Against the prior quarter it is up 16.0%.

EPS (Diluted)

-$0.07

YoY-75.0%

QoQ+22.2%

American Shared Hospital Services earned -$0.07 per diluted share (EPS) in Q2 2026. This represents a decrease of 75.0% from the same quarter a year earlier. Against the prior quarter it is up 22.2%.

Cash & Balance Sheet

Free Cash Flow

$2.2M

YoY+195.8%

QoQ+3.3%

5Y CAGR+60.0%

10Y CAGR+4.2%

American Shared Hospital Services generated $2.2M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 195.8% from the same quarter a year earlier. Against the prior quarter it is up 3.3%.

Cash & Debt

$6.5M

YoY-41.2%

QoQ+30.9%

5Y CAGR-4.8%

10Y CAGR+14.0%

American Shared Hospital Services held $6.5M in cash against $16.2M in long-term debt as of Q2 2026.

Shares Outstanding

YoY+2.2%

QoQ+0.4%

5Y CAGR+2.5%

10Y CAGR+2.2%

American Shared Hospital Services had 7M shares outstanding in Q2 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

17.0%

YoY-6.0pp

QoQ-1.2pp

5Y change-18.9pp

10Y change-23.7pp

American Shared Hospital Services's gross margin was 17.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 6.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.

Operating Margin

-10.8%

YoY-3.1pp

QoQ+2.2pp

5Y change-18.6pp

10Y change-20.6pp

American Shared Hospital Services's operating margin was -10.8% in Q2 2026, reflecting core business profitability. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Net Margin

-6.1%

YoY-2.1pp

QoQ+2.5pp

5Y change-4.2pp

10Y change-8.2pp

American Shared Hospital Services's net profit margin was -6.1% in Q2 2026, showing the share of revenue converted to profit. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Return on Equity

-2.2%

YoY-1.1pp

QoQ+0.4pp

5Y change-1.8pp

10Y change-2.7pp

American Shared Hospital Services's ROE was -2.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Capital Allocation

Capital Expenditures

$58K

YoY-96.9%

QoQ+41.5%

5Y CAGR-41.4%

10Y CAGR-13.3%

American Shared Hospital Services invested $58K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 96.9% from the same quarter a year earlier. Against the prior quarter it is up 41.5%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

AMS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$30.4M	$28.1M-0.9%	$28.3M+32.9%	$21.3M+8.0%	$19.7M+12.0%	$17.6M-1.2%	$17.8M-13.4%	$20.6M+4.5%	$19.7M+0.8%	$19.6M+4.6%	$18.7M+13.0%	$16.5M+7.3%	$15.4M-12.3%	$17.6M+3.1%	$17.0M-23.3%	$22.2M
Cost of Revenue	$25.2M	$23.0M+20.2%	$19.2M+59.9%	$12.0M+5.4%	$11.4M+4.2%	$10.9M-18.5%	$13.4M	N/A	$12.2M+12.3%	$10.9M+10.0%	$9.9M+0.7%	$9.8M-3.0%	$10.1M-4.7%	$10.6M+5.2%	$10.1M-28.9%	$14.2M
Gross Profit	$5.2M	$5.1M-44.9%	$9.2M-1.7%	$9.3M+11.5%	$8.4M+24.6%	$6.7M+50.6%	$4.5M-35.5%	$6.9M-7.6%	$7.5M-13.6%	$8.7M-1.5%	$8.8M+31.0%	$6.7M+27.2%	$5.3M-24.0%	$6.9M+0.2%	$6.9M-13.3%	$8.0M
SG&A Expenses	$7.5M	$7.1M-4.4%	$7.4M+5.5%	$7.0M+36.5%	$5.1M+13.6%	$4.5M-1.7%	$4.6M+13.5%	$4.1M+1.7%	$4.0M-7.6%	$4.3M+13.7%	$3.8M+8.8%	$3.5M-3.7%	$3.6M-9.8%	$4.0M-0.5%	$4.0M+0.1%	$4.0M
Operating Income	-$3.6M	-$3.6M-27.9%	-$2.8M-1138.9%	$270K-88.9%	$2.4M+79.9%	$1.4M+114.3%	-$9.5M-713.7%	$1.5M-17.1%	$1.9M-22.9%	$2.4M-26.6%	$3.3M+66.0%	$2.0M+4060.0%	-$50K-104.5%	$1.1M+53.4%	$730K-54.1%	$1.6M
EBITDA	N/A	$2.1M-36.9%	$3.4M-38.0%	$5.4M-24.7%	$7.2M+14.1%	$6.3M+353.6%	-$2.5M-127.8%	$9.0M+3.2%	$8.7M-4.5%	$9.1M-5.4%	$9.6M+17.7%	$8.2M+29.0%	$6.3M-15.9%	$7.5M+10.3%	$6.8M-13.2%	$7.9M
Interest Expense	$1.3M	$1.6M+5.0%	$1.5M+34.8%	$1.1M+38.0%	$806K+9.1%	$739K-30.1%	$1.1M-19.8%	$1.3M-19.2%	$1.6M-15.4%	$1.9M+12.9%	$1.7M+37.8%	$1.2M-27.1%	$1.7M-5.6%	$1.8M-16.5%	$2.2M-9.0%	$2.4M
Income Tax	$78K	-$493K-67.1%	-$295K-168.4%	$431K-55.2%	$963K+258.0%	$269K+115.5%	-$1.7M-1457.0%	$128K-71.6%	$451K+140.9%	-$1.1M-217.0%	$943K+117.3%	$434K+236.4%	$129K+53.6%	$84K-21.5%	$107K-48.6%	$208K
Net Income	-$1.8M	-$1.6M-171.0%	$2.2M+258.4%	$610K-54.1%	$1.3M+584.5%	$194K+102.7%	-$7.1M-1171.0%	$659K-35.6%	$1.0M-46.8%	$1.9M+106.8%	$930K+161.1%	-$1.5M-59.9%	-$952K-205.1%	-$312K-921.1%	$38K-92.5%	$506K
EPS (Basic)	N/A	-$0.23-167.6%	$0.34+240.0%	$0.10-52.4%	$0.21+600.0%	$0.03+102.6%	-$1.14-1136.4%	$0.11-38.9%	$0.18-45.5%	$0.33+94.1%	$0.17+160.7%	-$0.28-47.4%	-$0.19-171.4%	-$0.07-800.0%	$0.01-90.9%	$0.11
EPS (Diluted)	-$0.25	-$0.23-169.7%	$0.33+230.0%	$0.10-52.4%	$0.21+600.0%	$0.03+102.6%	-$1.14-1136.4%	$0.11-35.3%	$0.17-48.5%	$0.33+94.1%	$0.17+160.7%	-$0.28-47.4%	-$0.19-171.4%	-$0.07-800.0%	$0.01-90.9%	$0.11
Diluted Shares (Avg)	N/A	7M-1.3%	7M+4.8%	6M+1.4%	6M+4.0%	6M-2.0%	6M+4.2%	6M+1.3%	6M-0.5%	6M+5.4%	6M+1.2%	6M+9.8%	5M	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q/A
Revenue	$8.4M+19.2%	$7.1M+15.9%	$7.7M-14.8%	$7.2M+2.5%	$7.1M+0.2%	$6.1M+17.2%	$9.1M+59.2%	$7.0M+36.3%
Cost of Revenue	$7.0M+28.6%	$5.8M+12.1%	$6.8M+16.3%	$5.6M-0.8%	$5.4M+18.6%	$5.2M+68.2%	$5.9M+103.5%	$5.6M+85.7%
Gross Profit	$1.4M-12.1%	$1.3M+36.7%	$906K-71.7%	$1.6M+15.8%	$1.6M-34.0%	$942K-56.0%	$3.2M+13.8%	$1.4M-34.8%
SG&A Expenses	$2.0M+17.0%	$1.9M+5.6%	$2.0M+16.2%	$1.5M-20.0%	$1.7M-7.9%	$1.8M-3.8%	$1.7M-2.9%	$1.9M+10.8%
Operating Income	-$910K-67.3%	-$924K+28.9%	-$1.4M+23.4%	-$344K+61.3%	-$544K-54300.0%	-$1.3M-1428.2%	-$1.8M-549.6%	-$889K-1087.8%
EBITDA	$436K-54.8%	$370K+146.7%	-$98K+37.6%	$1.1M+47.0%	$964K-36.7%	$150K-88.0%	-$157K-109.3%	$755K-44.3%
Interest Expense	$301K-29.7%	$302K-30.3%	$321K-25.2%	$392K+16.7%	$428K+11.2%	$433K+24.1%	$429K+49.5%	$336K+21.3%
Income Tax	$135K+742.9%	$92K+128.5%	-$197K-286.3%	$48K+128.4%	-$21K+32.3%	-$323K-634.1%	-$51K-115.1%	-$169K-381.7%
Net Income	-$514K-83.6%	-$612K+2.1%	-$631K+52.5%	-$17K+91.8%	-$280K-107.8%	-$625K-625.2%	-$1.3M-420.0%	-$207K-275.4%
EPS (Basic)	-$0.07-75.0%	-$0.09+10.0%	-$0.09+55.0%	$0.00+100.0%	-$0.04-107.1%	-$0.10-600.0%	-$0.20-385.7%	-$0.03-250.0%
EPS (Diluted)	-$0.07-75.0%	-$0.09+10.0%	-$0.09+57.1%	$0.00+100.0%	-$0.04-107.3%	-$0.10-600.0%	-$0.21-400.0%	-$0.03-250.0%
Diluted Shares (Avg)	7M+4.4%	7M+2.3%	N/A	7M+2.3%	7M0.0%	7M-0.1%	N/A	6M+0.8%

Not reported in any period shown, so not listed: R&D Expenses.

AMS Balance Sheet

AMS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$55.5M-7.8%	$60.2M+25.0%	$48.2M+9.6%	$44.0M-3.2%	$45.4M+4.1%	$43.7M-18.8%	$53.8M-6.5%	$57.5M-1.2%	$58.2M-4.0%	$60.6M+12.0%	$54.1M-19.9%	$67.5M-5.9%	$71.7M-2.2%	$73.3M-1.6%	$74.5M
Current Assets	$17.7M-32.5%	$26.3M+28.4%	$20.5M+9.3%	$18.7M+24.1%	$15.1M+39.1%	$10.8M+1.0%	$10.7M+8.0%	$9.9M+11.8%	$8.9M+13.1%	$7.9M+30.9%	$6.0M-57.8%	$14.2M+84.9%	$7.7M+10.8%	$7.0M-60.5%	$17.6M
Cash & Equivalents	$3.5M-68.6%	$11.0M-19.5%	$13.7M+11.0%	$12.3M+51.4%	$8.1M+105.6%	$4.0M+177.2%	$1.4M-0.9%	$1.4M-33.0%	$2.2M-25.0%	$2.9M+30.0%	$2.2M+108.6%	$1.1M-44.5%	$1.9M+22.1%	$1.6M-39.4%	$2.6M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$10.5M-9.4%	$11.6M+167.3%	$4.3M+14.3%	$3.8M-9.7%	$4.2M-2.1%	$4.3M-37.6%	$6.9M+25.3%	$5.5M+9.6%	$5.0M+22.9%	$4.1M+34.5%	$3.0M-4.8%	$3.2M-29.4%	$4.5M+22.0%	$3.7M-19.5%	$4.6M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$27.8M-7.9%	$30.2M+37.9%	$21.9M+19.4%	$18.3M-13.5%	$21.2M-13.1%	$24.4M-12.1%	$27.8M-14.4%	$32.4M-5.6%	$34.3M-12.2%	$39.1M+15.1%	$34.0M-26.3%	$46.1M-11.5%	$52.1M+15.3%	$45.2M-16.8%	$54.3M
Current Liabilities	$23.4M+125.3%	$10.4M-3.5%	$10.8M+108.3%	$5.2M-12.2%	$5.9M-52.4%	$12.4M+50.7%	$8.2M-13.3%	$9.5M+5.2%	$9.0M+3.8%	$8.7M-0.2%	$8.7M-46.5%	$16.3M+37.9%	$11.8M+22.1%	$9.7M-2.9%	$9.9M
Non-Current Liabilities	$4.3M-78.0%	$19.8M+78.0%	$11.1M-15.6%	$13.2M-14.0%	$15.3M+27.5%	$12.0M-38.6%	$19.5M-14.8%	$22.9M-9.4%	$25.3M-16.8%	$30.4M+20.3%	$25.3M-15.3%	$29.9M-26.0%	$40.3M+13.4%	$35.6M-19.9%	$44.4M
Long-Term Debt	$0-100.0%	$17.3M+57.1%	$11.0M-9.5%	$12.2M-14.8%	$14.3M+316.4%	$3.4M+76.0%	$2.0M-41.4%	$3.3M-7.4%	$3.6M-29.5%	$5.1M-46.8%	$9.6M-10.5%	$10.7M-31.0%	$15.5M-12.5%	$17.8M+15.6%	$15.4M
Total Equity	$24.0M-4.6%	$25.2M+11.3%	$22.6M+4.6%	$21.6M+8.7%	$19.9M+3.2%	$19.3M-26.0%	$26.0M+3.7%	$25.1M+5.2%	$23.9M+11.0%	$21.5M+6.8%	$20.1M-6.0%	$21.4M+9.2%	$19.6M-1.6%	$19.9M-1.4%	$20.2M
Retained Earnings	$4.3M-26.7%	$5.8M+60.2%	$3.6M+20.2%	$3.0M+78.5%	$1.7M+13.0%	$1.5M-82.5%	$8.6M+8.3%	$7.9M+14.9%	$6.9M+38.8%	$5.0M+23.1%	$4.0M-27.5%	$5.5M-14.7%	$6.5M-4.6%	$6.8M+0.6%	$6.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q/A
Total Assets	$52.5M-17.3%	$54.7M-13.6%	$55.5M-7.8%	$59.6M-5.8%	$63.5M+4.4%	$63.3M+26.3%	$60.2M+25.0%	$63.3M+33.6%
Current Assets	$17.4M-28.9%	$18.3M-23.0%	$17.7M-32.5%	$20.6M-19.9%	$24.4M-4.7%	$23.7M+11.1%	$26.3M+28.4%	$25.7M+26.3%
Cash & Equivalents	$6.5M-41.2%	$5.0M-55.8%	$3.5M-68.6%	$5.1M-63.2%	$11.1M-22.2%	$11.2M-12.1%	$11.0M-19.5%	$13.8M-4.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$8.3M-13.1%	$10.6M+20.9%	$10.5M-9.4%	$11.8M+36.7%	$9.6M+11.3%	$8.7M+35.9%	$11.6M+167.3%	$8.6M+116.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%	$1.3M0.0%
Total Liabilities	$26.7M-23.0%	$28.0M-17.8%	$27.8M-7.9%	$31.0M-1.3%	$34.6M+21.7%	$34.1M+43.6%	$30.2M+37.9%	$31.4M+47.2%
Current Liabilities	$22.4M+7.5%	$23.7M+86.6%	$23.4M+125.3%	$25.8M+46.9%	$20.9M+56.4%	$12.7M+17.9%	$10.4M-3.5%	$17.6M+74.8%
Non-Current Liabilities	$4.3M-69.1%	$4.3M-79.9%	$4.3M-78.0%	$5.2M-62.3%	$13.8M-8.9%	$21.4M+65.0%	$19.8M+78.0%	$13.9M+22.8%
Long-Term Debt	$16.2M+75.8%	$16.8M+0.3%	$0-100.0%	$0-100.0%	$9.2M-23.5%	$16.8M+30.3%	$17.3M+57.1%	$10.8M+3.5%
Total Equity	$23.1M-5.6%	$23.5M-4.6%	$24.0M-4.6%	$24.6M-7.0%	$24.5M-7.8%	$24.6M+7.9%	$25.2M+11.3%	$26.4M+19.5%
Retained Earnings	$3.1M-36.1%	$3.6M-29.7%	$4.3M-26.7%	$4.9M-31.5%	$4.9M-33.2%	$5.2M+38.5%	$5.8M+60.2%	$7.1M+122.2%

Not reported in any period shown, so not listed: Inventory.

AMS Cash Flow Statement

AMS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$5.4M	$3.1M+1755.1%	$167K-97.1%	$5.7M-21.0%	$7.2M+15.4%	$6.3M-35.7%	$9.7M+21.1%	$8.0M-0.2%	$8.1M+2.7%	$7.9M-6.3%	$8.4M-2.0%	$8.5M+26.2%	$6.8M-16.1%	$8.1M+17.6%	$6.9M+0.3%	$6.8M
Depreciation & Amortization	N/A	$5.7M-7.5%	$6.2M+19.5%	$5.2M+8.0%	$4.8M-3.8%	$5.0M-28.7%	$7.0M-6.0%	$7.4M+8.7%	$6.8M+2.1%	$6.7M+5.5%	$6.3M+2.2%	$6.2M-3.0%	$6.4M-0.4%	$6.4M+5.2%	$6.1M-2.8%	$6.3M
Stock-Based Compensation	N/A	$404K+8.3%	$373K-4.1%	$389K-2.5%	$399K-5.0%	$420K+40.5%	$299K+30.0%	$230K+3.1%	$223K-31.0%	$323K+50.2%	$215K-4.9%	$226K+63.8%	$138K+56.8%	$88K+18.9%	$74K-40.8%	$125K
Capital Expenditures	$1.8M	$7.6M-3.8%	$7.9M+26.5%	$6.3M+1516.8%	$388K-76.8%	$1.7M+267.9%	$455K-54.0%	$990K-37.2%	$1.6M+96.4%	$803K-22.9%	$1.0M+15.8%	$900K-82.7%	$5.2M+204.8%	$1.7M-74.2%	$6.6M+18.2%	$5.6M
Free Cash Flow	-$433K	-$4.5M+41.6%	-$7.8M-1300.2%	-$555K-108.1%	$6.8M+49.1%	$4.6M-50.6%	$9.3M+31.6%	$7.1M+8.8%	$6.5M-8.0%	$7.0M-3.9%	$7.3M-4.1%	$7.6M+389.9%	$1.6M-75.5%	$6.4M+2608.9%	$235K-81.0%	$1.2M
Investing Cash Flow	-$1.8M	-$7.6M-7.4%	-$7.1M-13.3%	-$6.3M-1516.8%	-$388K+76.8%	-$1.7M+29.9%	-$2.4M-141.3%	-$990K+35.1%	-$1.5M-133.7%	-$653K+37.3%	-$1.0M-14.5%	-$910K	N/A	-$1.7M+74.1%	-$6.7M-17.9%	-$5.7M
Financing Cash Flow	-$8.1M	-$3.0M-168.7%	$4.4M+130.6%	$1.9M+171.9%	-$2.7M-305.6%	-$655K+86.4%	-$4.8M+32.0%	-$7.1M+2.4%	-$7.2M+7.3%	-$7.8M-20.8%	-$6.5M+0.2%	-$6.5M	N/A	-$6.0M-392.6%	-$1.2M-4113.8%	-$29K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$2K	$0-100.0%	$28K	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q/A
Operating Cash Flow	$2.2M+701.1%	$2.1M-14.1%	-$704K-356.9%	$1.7M+254.0%	-$372K-128.9%	$2.5M+234.2%	$274K+109.0%	$472K-86.8%
Depreciation & Amortization	$1.3M-10.7%	$1.3M-10.7%	$1.3M-22.1%	$1.5M-11.6%	$1.5M-1.0%	$1.4M+8.6%	$1.7M+29.6%	$1.6M+30.0%
Stock-Based Compensation	N/A	$101K+13.5%	N/A	N/A	N/A	$89K-9.2%	N/A	N/A
Capital Expenditures	$58K-96.9%	$41K-99.0%	-$2.0M-57.4%	$3.7M+321.2%	$1.9M+56.3%	$4.0M+239.4%	$4.7M+4704.1%	$879K-75.7%
Free Cash Flow	$2.2M+195.8%	$2.1M+239.4%	-$2.7M+38.7%	-$2.0M-399.0%	-$2.3M-3347.1%	-$1.5M+50.4%	-$4.4M-38.9%	-$407K-698.0%
Investing Cash Flow	-$58K+96.9%	-$41K+99.0%	$2.0M+145.5%	-$3.7M-425.9%	-$1.9M-122.9%	-$4.0M-239.4%	-$4.4M-4400.0%	-$704K+80.5%
Financing Cash Flow	-$640K-130.3%	-$597K-134.5%	-$2.9M-326.0%	-$4.0M-2134.5%	$2.1M+109.0%	$1.7M-24.3%	$1.3M-44.2%	-$177K-119.4%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AMS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	18.0%-14.4pp	32.4%-11.4pp	43.8%+1.4pp	42.4%+4.3pp	38.2%+13.1pp	25.0%-8.5pp	33.6%-4.4pp	38.0%-6.3pp	44.3%-2.7pp	47.0%+6.5pp	40.6%+6.3pp	34.2%-5.2pp	39.5%-1.2pp	40.6%+4.7pp	36.0%
Operating Margin	-12.8%-2.9pp	-9.9%-11.2pp	1.3%-11.0pp	12.3%+4.7pp	7.7%+60.7pp	-53.0%-60.5pp	7.5%-2.0pp	9.4%-2.9pp	12.3%-5.2pp	17.6%+5.6pp	12.0%+12.3pp	-0.3%-6.7pp	6.4%+2.1pp	4.3%-2.9pp	7.1%
Net Margin	-5.5%-13.2pp	7.7%+4.9pp	2.9%-3.9pp	6.7%+5.6pp	1.1%+40.7pp	-39.6%-42.8pp	3.2%-2.0pp	5.2%-4.6pp	9.8%+4.9pp	5.0%+14.2pp	-9.2%-3.0pp	-6.2%-4.4pp	-1.8%-2.0pp	0.2%-2.1pp	2.3%
Return on Equity	-6.5%-15.1pp	8.7%+6.0pp	2.7%-3.4pp	6.1%+5.2pp	1.0%+37.6pp	-36.6%-39.1pp	2.5%-1.6pp	4.1%-4.0pp	8.1%+3.7pp	4.3%+11.9pp	-7.6%-3.1pp	-4.4%-2.9pp	-1.6%-1.8pp	0.2%-2.3pp	2.5%
Return on Assets	-2.8%-6.4pp	3.6%+2.4pp	1.3%-1.8pp	3.0%+2.6pp	0.4%+16.6pp	-16.2%-17.4pp	1.2%-0.5pp	1.8%-1.5pp	3.3%+1.8pp	1.5%+4.3pp	-2.8%-1.4pp	-1.4%-1.0pp	-0.4%-0.5pp	0.1%-0.6pp	0.7%
Current Ratio	0.76-1.8x	2.52+0.6x	1.90-1.7x	3.62+1.1x	2.56+1.7x	0.88-0.4x	1.31+0.3x	1.05+0.1x	0.99+0.1x	0.91+0.2x	0.69-0.2x	0.88+0.2x	0.65-0.1x	0.72-1.1x	1.77
Debt-to-Equity	0.00-0.7x	0.69+0.2x	0.49-0.1x	0.56-0.2x	0.72+0.5x	0.18+0.1x	0.08-0.1x	0.130.0x	0.15-0.1x	0.24-0.2x	0.480.0x	0.50-0.3x	0.79-0.1x	0.89+0.1x	0.76
Asset Turnover	0.510.0x	0.470.0x	0.440.0x	0.45+0.1x	0.390.0x	0.410.0x	0.380.0x	0.340.0x	0.340.0x	0.310.0x	0.31+0.1x	0.230.0x	0.250.0x	0.23-0.1x	0.30
FCF Margin	-16.2%+11.3pp	-27.4%-24.8pp	-2.6%-37.3pp	34.7%+8.6pp	26.1%-26.0pp	52.1%+17.8pp	34.3%+1.4pp	32.9%-3.1pp	36.0%-3.2pp	39.2%-7.0pp	46.2%+36.1pp	10.1%-26.1pp	36.2%+34.8pp	1.4%-4.2pp	5.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q/A
Gross Margin	17.0%-6.0pp	18.2%+2.8pp	11.7%-23.6pp	22.1%+2.5pp	23.1%-11.9pp	15.4%-25.7pp	35.3%-14.1pp	19.6%-21.4pp
Operating Margin	-10.8%-3.1pp	-13.0%+8.2pp	-18.1%+2.1pp	-4.8%+7.9pp	-7.7%-7.7pp	-21.3%-19.6pp	-20.2%-27.3pp	-12.7%-14.5pp
Net Margin	-6.1%-2.1pp	-8.6%+1.6pp	-8.2%+6.5pp	-0.2%+2.7pp	-4.0%-55.0pp	-10.2%-12.5pp	-14.6%-21.9pp	-3.0%-5.3pp
Return on Equity	-2.2%-1.1pp	-2.6%-0.1pp	-2.6%+2.6pp	-0.1%+0.7pp	-1.1%-14.7pp	-2.5%-3.1pp	-5.3%-7.1pp	-0.8%-1.3pp
Return on Assets	-1.0%-0.5pp	-1.1%-0.1pp	-1.1%+1.1pp	0.0%+0.3pp	-0.4%-6.4pp	-1.0%-1.2pp	-2.2%-3.1pp	-0.3%-0.6pp
Current Ratio	0.77-0.4x	0.77-1.1x	0.76-1.8x	0.80-0.7x	1.17-0.8x	1.87-0.1x	2.52+0.6x	1.46-0.6x
Debt-to-Equity	0.70+0.3x	0.720.0x	0.00-0.7x	0.00-0.4x	0.38-0.1x	0.68+0.1x	0.69+0.2x	0.41-0.1x
Asset Turnover	0.160.0x	0.130.0x	0.140.0x	0.120.0x	0.110.0x	0.100.0x	0.150.0x	0.110.0x
FCF Margin	25.8%+58.0pp	29.8%+54.5pp	-34.8%+13.6pp	-28.3%-22.5pp	-32.1%-33.1pp	-24.7%+33.7pp	-48.4%+7.1pp	-5.8%-4.8pp

Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
American Shared Hospital Services AMS	FY2025	$28.1M	-$1.6M	-5.5%	$8.8M	37/100
Concord Medical Services Holding Limited CCM	FY2025	$65.9M	-$13.3M	-20.2%	$13.6M	29/100
Basel Medical Group Ltd BMGL	FY2025	$8.9M	-$8.4M	-94.0%	$5.2M	17/100
ModivCare Inc. MODV	FY2024	$2.8B	-$201.3M	-7.2%	$6.2M	20/100
Cryo-Cell International Inc. CCEL	FY2025	$31.6M	-$2.4M	-7.7%	$31.5M	27/100
NewGenIvf Group Limited NIVF	FY2025	$4.7M	$9.9M	N/A	$2.9M	31/100

Where American Shared Hospital Services Ranks

Frequently Asked Questions

What is American Shared Hospital Services's annual revenue?

American Shared Hospital Services (AMS) reported $28.1M in total revenue for fiscal year 2025. This represents a -0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is American Shared Hospital Services's revenue growing?

American Shared Hospital Services (AMS) revenue declined by 0.9% year-over-year, from $28.3M to $28.1M in fiscal year 2025.

Is American Shared Hospital Services profitable?

No, American Shared Hospital Services (AMS) reported a net income of -$1.6M in fiscal year 2025, with a net profit margin of -5.5%.

What is American Shared Hospital Services's EBITDA?

American Shared Hospital Services (AMS) had EBITDA of $2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does American Shared Hospital Services have?

As of fiscal year 2025, American Shared Hospital Services (AMS) had $3.5M in cash and equivalents against $0 in long-term debt.

What is American Shared Hospital Services's gross margin?

American Shared Hospital Services (AMS) had a gross margin of 18.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is American Shared Hospital Services's operating margin?

American Shared Hospital Services (AMS) had an operating margin of -12.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is American Shared Hospital Services's net profit margin?

American Shared Hospital Services (AMS) had a net profit margin of -5.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is American Shared Hospital Services's return on equity (ROE)?

American Shared Hospital Services (AMS) has a return on equity of -6.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is American Shared Hospital Services's free cash flow?

American Shared Hospital Services (AMS) recorded an outflow of $4.5M in free cash flow during fiscal year 2025. This represents a 41.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is American Shared Hospital Services's operating cash flow?

American Shared Hospital Services (AMS) generated $3.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are American Shared Hospital Services's total assets?

American Shared Hospital Services (AMS) had $55.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are American Shared Hospital Services's capital expenditures?

American Shared Hospital Services (AMS) invested $7.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does American Shared Hospital Services have outstanding?

American Shared Hospital Services (AMS) had 7M shares outstanding as of fiscal year 2025.

What is American Shared Hospital Services's current ratio?

American Shared Hospital Services (AMS) had a current ratio of 0.76 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is American Shared Hospital Services's debt-to-equity ratio?

American Shared Hospital Services (AMS) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is American Shared Hospital Services's return on assets (ROA)?

American Shared Hospital Services (AMS) had a return on assets of -2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is American Shared Hospital Services's P/E ratio?

American Shared Hospital Services (AMS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $8.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is American Shared Hospital Services's price-to-sales ratio?

American Shared Hospital Services (AMS) trades at 0.3x sales, its market capitalization divided by revenue of $30.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $8.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is American Shared Hospital Services's Altman Z-Score?

American Shared Hospital Services (AMS) has an Altman Z-Score of 0.47, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is American Shared Hospital Services's Piotroski F-Score?

American Shared Hospital Services (AMS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are American Shared Hospital Services's earnings high quality?

American Shared Hospital Services (AMS) reported a net loss of $1.6M while generating $3.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can American Shared Hospital Services cover its interest payments?

American Shared Hospital Services (AMS) reported an operating loss of $3.6M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is American Shared Hospital Services?

American Shared Hospital Services (AMS) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.